198 related articles for article (PubMed ID: 21930711)
1. Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1).
Aranda-Orgillés B; Rutschow D; Zeller R; Karagiannidis AI; Köhler A; Chen C; Wilson T; Krause S; Roepcke S; Lilley D; Schneider R; Schweiger S
J Biol Chem; 2011 Nov; 286(46):39945-57. PubMed ID: 21930711
[TBL] [Abstract][Full Text] [Related]
2. MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac.
Du H; Wu K; Didoronkute A; Levy MV; Todi N; Shchelokova A; Massiah MA
PLoS One; 2014; 9(9):e107428. PubMed ID: 25207814
[TBL] [Abstract][Full Text] [Related]
3. The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex.
Aranda-Orgillés B; Trockenbacher A; Winter J; Aigner J; Köhler A; Jastrzebska E; Stahl J; Müller EC; Otto A; Wanker EE; Schneider R; Schweiger S
Hum Genet; 2008 Mar; 123(2):163-76. PubMed ID: 18172692
[TBL] [Abstract][Full Text] [Related]
4. The E3 ubiquitin ligase MID1/TRIM18 promotes atypical ubiquitination of the BRCA2-associated factor 35, BRAF35.
Zanchetta ME; Napolitano LMR; Maddalo D; Meroni G
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1844-1854. PubMed ID: 28760657
[TBL] [Abstract][Full Text] [Related]
5. Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A.
Aranda-Orgillés B; Aigner J; Kunath M; Lurz R; Schneider R; Schweiger S
PLoS One; 2008; 3(10):e3507. PubMed ID: 18949047
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional observations of the P151L MID1 mutation reveal alpha4 plays a significant role in X-linked Opitz Syndrome.
Wright KM; Du H; Massiah MA
FEBS J; 2017 Jul; 284(14):2183-2193. PubMed ID: 28548391
[TBL] [Abstract][Full Text] [Related]
7. Control of mTORC1 signaling by the Opitz syndrome protein MID1.
Liu E; Knutzen CA; Krauss S; Schweiger S; Chiang GG
Proc Natl Acad Sci U S A; 2011 May; 108(21):8680-5. PubMed ID: 21555591
[TBL] [Abstract][Full Text] [Related]
8. Complex rearrangement of the exon 6 genomic region among Opitz G/BBB Syndrome MID1 alterations.
Migliore C; Athanasakis E; Dahoun S; Wonkam A; Lees M; Calabrese O; Connell F; Lynch SA; Izzi C; Pompilii E; Thakur S; van Maarle M; Wilson LC; Meroni G
Eur J Med Genet; 2013 Aug; 56(8):404-10. PubMed ID: 23791568
[TBL] [Abstract][Full Text] [Related]
9. Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex.
Krauss S; Griesche N; Jastrzebska E; Chen C; Rutschow D; Achmüller C; Dorn S; Boesch SM; Lalowski M; Wanker E; Schneider R; Schweiger S
Nat Commun; 2013; 4():1511. PubMed ID: 23443539
[TBL] [Abstract][Full Text] [Related]
10. Embryonic expression of the human MID1 gene and its mutations in Opitz syndrome.
Pinson L; Augé J; Audollent S; Mattéi G; Etchevers H; Gigarel N; Razavi F; Lacombe D; Odent S; Le Merrer M; Amiel J; Munnich A; Meroni G; Lyonnet S; Vekemans M; Attié-Bitach T
J Med Genet; 2004 May; 41(5):381-6. PubMed ID: 15121778
[No Abstract] [Full Text] [Related]
11. Mig12, a novel Opitz syndrome gene product partner, is expressed in the embryonic ventral midline and co-operates with Mid1 to bundle and stabilize microtubules.
Berti C; Fontanella B; Ferrentino R; Meroni G
BMC Cell Biol; 2004 Feb; 5():9. PubMed ID: 15070402
[TBL] [Abstract][Full Text] [Related]
12. A MID1 mutation associated with reduced penetrance of X-linked Opitz G/BBB syndrome.
Ruiter M; Kamsteeg EJ; Meroni G; de Vries BBA
Clin Dysmorphol; 2010 Oct; 19(4):195-197. PubMed ID: 20671548
[TBL] [Abstract][Full Text] [Related]
13. A structure-function study of MID1 mutations associated with a mild Opitz phenotype.
Mnayer L; Khuri S; Merheby HA; Meroni G; Elsas LJ
Mol Genet Metab; 2006 Mar; 87(3):198-203. PubMed ID: 16378742
[TBL] [Abstract][Full Text] [Related]
14. Evidence of functional redundancy between MID proteins: implications for the presentation of Opitz syndrome.
Granata A; Savery D; Hazan J; Cheung BM; Lumsden A; Quaderi NA
Dev Biol; 2005 Jan; 277(2):417-24. PubMed ID: 15617684
[TBL] [Abstract][Full Text] [Related]
15. TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis.
Collison AM; Li J; de Siqueira AP; Lv X; Toop HD; Morris JC; Starkey MR; Hansbro PM; Zhang J; Mattes J
BMC Pulm Med; 2019 Feb; 19(1):31. PubMed ID: 30732588
[TBL] [Abstract][Full Text] [Related]
16. Exon 2 duplication of the MID1 gene in a patient with a mild phenotype of Opitz G/BBB syndrome.
Hüning I; Kutsche K; Rajaei S; Erlandsson A; Lovmar L; Rundberg J; Stefanova M
Eur J Med Genet; 2013 Apr; 56(4):188-91. PubMed ID: 23354372
[TBL] [Abstract][Full Text] [Related]
17. The E3 ubiquitin ligase MID1 catalyzes ubiquitination and cleavage of Fu.
Schweiger S; Dorn S; Fuchs M; Köhler A; Matthes F; Müller EC; Wanker E; Schneider R; Krauß S
J Biol Chem; 2014 Nov; 289(46):31805-31817. PubMed ID: 25278022
[TBL] [Abstract][Full Text] [Related]
18. Detection and characterization of the in vitro e3 ligase activity of the human MID1 protein.
Han X; Du H; Massiah MA
J Mol Biol; 2011 Apr; 407(4):505-20. PubMed ID: 21296087
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation in MID1 in a patient with X-linked Opitz G/BBB syndrome.
Ji X; Xing Y; Xu Y; Liu Y; Chen Y; Tao J; Xiao B
Gene; 2014 Mar; 537(1):140-2. PubMed ID: 24374473
[TBL] [Abstract][Full Text] [Related]
20. The Opitz syndrome gene product, MID1, associates with microtubules.
Schweiger S; Foerster J; Lehmann T; Suckow V; Muller YA; Walter G; Davies T; Porter H; van Bokhoven H; Lunt PW; Traub P; Ropers HH
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2794-9. PubMed ID: 10077590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
